WO2000040942A2 - Improved biosensor device and method of manufacturing same - Google Patents

Improved biosensor device and method of manufacturing same Download PDF

Info

Publication number
WO2000040942A2
WO2000040942A2 PCT/US1999/029965 US9929965W WO0040942A2 WO 2000040942 A2 WO2000040942 A2 WO 2000040942A2 US 9929965 W US9929965 W US 9929965W WO 0040942 A2 WO0040942 A2 WO 0040942A2
Authority
WO
WIPO (PCT)
Prior art keywords
fibers
fiber
biosensor
devices
manufacturing
Prior art date
Application number
PCT/US1999/029965
Other languages
French (fr)
Other versions
WO2000040942A3 (en
Inventor
Timothy Noonan
James Noonan
Original Assignee
Drawn Optical Components, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Drawn Optical Components, Inc. filed Critical Drawn Optical Components, Inc.
Priority to MXPA01006126A priority Critical patent/MXPA01006126A/en
Priority to AU43241/00A priority patent/AU4324100A/en
Priority to CA002356634A priority patent/CA2356634A1/en
Priority to EP99972833A priority patent/EP1166077A4/en
Priority to JP2000592611A priority patent/JP2002534672A/en
Publication of WO2000040942A2 publication Critical patent/WO2000040942A2/en
Publication of WO2000040942A3 publication Critical patent/WO2000040942A3/en

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/508Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above
    • B01L3/5085Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above for multiple samples, e.g. microtitration plates
    • B01L3/50857Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above for multiple samples, e.g. microtitration plates using arrays or bundles of open capillaries for holding samples
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J19/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J19/0046Sequential or parallel reactions, e.g. for the synthesis of polypeptides or polynucleotides; Apparatus and devices for combinatorial chemistry or for making molecular arrays
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/75Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
    • G01N21/77Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
    • G01N21/7703Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator using reagent-clad optical fibres or optical waveguides
    • GPHYSICS
    • G02OPTICS
    • G02BOPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B6/00Light guides; Structural details of arrangements comprising light guides and other optical elements, e.g. couplings
    • G02B6/04Light guides; Structural details of arrangements comprising light guides and other optical elements, e.g. couplings formed by bundles of fibres
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277Apparatus
    • B01J2219/00497Features relating to the solid phase supports
    • B01J2219/00513Essentially linear supports
    • B01J2219/00524Essentially linear supports in the shape of fiber bundles
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277Apparatus
    • B01J2219/00497Features relating to the solid phase supports
    • B01J2219/00527Sheets
    • B01J2219/00536Sheets in the shape of disks
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583Features relative to the processes being carried out
    • B01J2219/00585Parallel processes
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583Features relative to the processes being carried out
    • B01J2219/00596Solid-phase processes
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583Features relative to the processes being carried out
    • B01J2219/00603Making arrays on substantially continuous surfaces
    • B01J2219/00605Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583Features relative to the processes being carried out
    • B01J2219/00603Making arrays on substantially continuous surfaces
    • B01J2219/00605Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
    • B01J2219/00612Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports the surface being inorganic
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583Features relative to the processes being carried out
    • B01J2219/00603Making arrays on substantially continuous surfaces
    • B01J2219/00605Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
    • B01J2219/00614Delimitation of the attachment areas
    • B01J2219/00621Delimitation of the attachment areas by physical means, e.g. trenches, raised areas
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583Features relative to the processes being carried out
    • B01J2219/00603Making arrays on substantially continuous surfaces
    • B01J2219/00605Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
    • B01J2219/00623Immobilisation or binding
    • B01J2219/00626Covalent
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583Features relative to the processes being carried out
    • B01J2219/00603Making arrays on substantially continuous surfaces
    • B01J2219/00659Two-dimensional arrays
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583Features relative to the processes being carried out
    • B01J2219/00603Making arrays on substantially continuous surfaces
    • B01J2219/00673Slice arrays
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00718Type of compounds synthesised
    • B01J2219/0072Organic compounds
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00718Type of compounds synthesised
    • B01J2219/0072Organic compounds
    • B01J2219/00722Nucleotides
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00718Type of compounds synthesised
    • B01J2219/0072Organic compounds
    • B01J2219/0074Biological products
    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00Libraries per se, e.g. arrays, mixtures
    • C40B40/04Libraries containing only organic compounds
    • C40B40/06Libraries containing nucleotides or polynucleotides, or derivatives thereof
    • GPHYSICS
    • G02OPTICS
    • G02BOPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B6/00Light guides; Structural details of arrangements comprising light guides and other optical elements, e.g. couplings
    • G02B6/04Light guides; Structural details of arrangements comprising light guides and other optical elements, e.g. couplings formed by bundles of fibres
    • G02B6/06Light guides; Structural details of arrangements comprising light guides and other optical elements, e.g. couplings formed by bundles of fibres the relative position of the fibres being the same at both ends, e.g. for transporting images
    • G02B6/08Light guides; Structural details of arrangements comprising light guides and other optical elements, e.g. couplings formed by bundles of fibres the relative position of the fibres being the same at both ends, e.g. for transporting images with fibre bundle in form of plate
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/14Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333Saccharide [e.g., DNA, etc.]

Definitions

  • This invention relates to a device which can serve as a biosensor device and which is useful for separation and detection of micro quantities of proteins and similar types of genetic materials and organic molecules and to a method of manufacturing such a device, which can be implemented as microarrays which may be used for high throughput screening applications, bioremediation and detection and quantification.
  • DNA analysis is an effective approach for the detection and identification of viruses, bacteria, and other microbes and is essential to the identification of genetic disorders.
  • the ability to detect DNA with a high level of specificity entails high resolution separation of RNA or DNA fragments, appropriate labeling chemistry for such fragments and the adaptation of high sensitivity sensors that are specific for the labeling chemistry employed.
  • DNA probe technology is now an established tool of the molecular biologist for revealing the presence of diagnostically significant cells, whether they be diseased cells from the subject or infectious micro organisms.
  • DNA analysis devices have experienced a miniaturization trend similar to that experienced in the electronics industry with the advent of integrated circuits.
  • Many of the same principles that have led to smaller and smaller micro processor devices have shrunk the size of a chemistry lab to a device no larger than the size of a dime.
  • the techniques are all aimed at producing a device having different, discreet areas that are sensitive to different genetic sequences. These areas, or probes, are formed using a number of techniques, including photo patterning methods, such as photolithography, which is a direct descendant from techniques used in the manufacture of micro processor chips; micro machining, where tiny channels are machined into a chip to hold various test media; and other methods of precisely depositing test media upon chips in a precisely defined pattern.
  • biosensor chips While these methods do allow for the manufacture of acceptable biosensor chips, they do have a number of drawbacks.
  • One significant drawback is the sophistication and expense of photo patterning, micro machining and micro-media deposition devices that are capable of producing biosensor chips including hundreds or thousands of individual probes.
  • the use of these prior art methods requires extreme precision in the deposition of test materials since their deposition involves microscopic quantities and positions. This also leads to significant quality control issues, since a single biosensor chip can have literally thousands of separate probes, each of which requires testing or verification. Due to these drawbacks and limitations, biosensor chips are expensive to manufacture and although they provide significant improvements in the state of the art, they have not yet experienced wide scale implementation. In addition, the technology is too expensive for implementation with respect to low cost diagnostic tests.
  • the disclosed invention provides a new biosensor device which improves upon the prior art by providing high reliability sensors that can be manufactured on an extremely low cost basis.
  • the improved biosensor devices are manufactured by first synthesizing a plurality of functional moieties onto a plurality of fibers, wherein each fiber receives one moiety. Once the functional moieties are synthesized onto the fibers, the fibers are bundled in a predetermined arrangement. The bundled fibers are then bonded together to fix their predetermined arrangement. Finally, the bonded fiber bundle is "sliced" into a plurality of devices (chips) .
  • the fibers comprise glass fibers.
  • Fig. 1 is a flow diagram showing the steps included in the disclosed method of manufacturing a biosensor device
  • Fig. 2 is a detailed block diagram of a method of synthesizing DNA onto fibers to be included in the biosensor device of the present invention
  • Fig. 3 is a functiono nal block diagram of the disclosed method of manufacturing biosensor devices.
  • Fig. 4 is a top view of a biosensor device manufactured according to the principles of the present invention.
  • Method 100 begins by synthesizing functional moieties onto a plurality of fibers, step 110.
  • the fibers can be various diameters and may be solid or hollow. At least one fiber receives several moieties of the same species. However, as will become evident below, more than one fiber may receive the same functional moiety.
  • the functional moieties selected will be dependent upon the specific testing protocol or protocols for which the biosensor device is designed.
  • functional moieties may include DNA oligonucleotides for DNA testing biosensor devices.
  • the functional moieties may include proteins, peptides, antibodies or other chemical functional groups.
  • the fibers comprise glass fibers.
  • the fibers are synthesized with their respective functional moieties, the fibers are bundled into a predetermined arrangement, step 120, such as a circle, square, etc.
  • the bundled fibers are then bonded to fix the predetermined arrangement, step 130.
  • Bonding may include fiber fusion or any one of a number of well known biologically inert bonding adhesives such as polysulfone adhesive available from Huls of Germany under the brand name glassclad, or other biologically inert adhesive used in the biopharmaceutical industry.
  • the biologically inert bonding medium thus fills the interstices intermediate the plurality of fibers, thereby separating the functional moieties on the plurality of fibers included in the bundle.
  • the fiber bundle is sliced, step 140, to form a plurality of individual "chips" or devices.
  • the slices may be along an axis perpendicular to a longitudinal axis of the fibers.
  • each individual biosensor device may include a portion of each fiber included in the fiber bundle.
  • different slicing orientations will result in biosensor devices having different configurations.
  • the invention contemplates linearly aligned fibers, which are bonded in their linear arrangement.
  • the linearly arranged fiber bundle can then be cut to form wafers having linearly orientated fibers upon which the various functional moieties are synthesized.
  • a device may include many fibers that have the same functional moiety synthesized thereupon. These like fibers can be arranged to form a large region responsive to certain chemicals. Thus, larger, macroscopic biosensor devices can be produced.
  • the biosensor devices manufactured according to the principles of the present invention could include literally thousands of fibers synthesized with distinct functional moieties. In this case, analysis of such a biosensor device after it is exposed to a sample would require sophisticated readers and processors, such as lasers, micro computers and optical recognition devices.
  • the glass fibers used are selected from the group consisting of lead borosilicate, soda- lime, rare earth lead, rare earth crown, flint, short flint, crown, silica, fused silica and borosilicate.
  • the invention is not limited to these specific types of glass.
  • Fig. 2 shows, in detail, one embodiment of the step of the invention wherein the functional moieties are synthesized onto the fibers.
  • the fibers include glass fibers and the functional moieties synthesized thereupon comprise DNA oligonucleotides. If the invention is practiced using plastic or polymer fibers, the method 200 would begin with step 225.
  • the method 200 begins by treating each glass fiber in generally a 35 percent and 40 percent HC1 solution at substantially 100°C for substantially three hours, step 205. This step exposes the hydroxy group of the glass fibers.
  • each HC1 treated glass fiber is washed with deionized water until its pH reaches substantially 6.5.
  • each washed fiber is baked at substantially 120°C for substantially two hours, step 215.
  • each fiber is cooled to substantially ambient temperature, step 220.
  • step 225 each glass fiber is packed into a synthesis column, such as a one " //mole" column manufactured by PerSeptive Biosystems. The fiber is then ready to accept the syntheses of a DNA oligonucleotide.
  • a DNA oligonucleotide is synthesized onto the fiber , step 230, using an automated DNA synthesizer such as those available from PerSeptive Biosystems or Perkin Elmer . This is accomplished with either the standard protocol or with a minor variation to the manufacturer' s standard synthesis protocol namely, an increased coupling time .
  • the standard protocol typically has three (3) coupling steps or stages totaling 5 minutes coupling time.
  • the present invention contemplates three (3) coupling stages of 10 minu tes, 4 minutes and 1 minute respectively, although this is not a limitation of the present invention. Coupling time is a factor of the fiber type used and whether or not the fibers are hollow or not.
  • the column is dried under a vacuum for substantially ten minutes, step 235.
  • the fiber which now includes a DNA oligonucleotide synthesized thereupon is treated with a one ml concentrated ammonium hydroxide solution at a temperature of substantially 55°C for a period of substantially six hours. This step will cleave the DNA ologonucleotide (the functional moiety) from the fiber so that it can be analyzed for quality control purposes.
  • Analytical testing such as absorption measurement of the ammonium hydroxide solution at 260 nm indicates that there is no loss of the DNA oligonucleotide from the glass fiber or if a cleavable linker was added then absorption at 260 nm indicates the presence of DNA.
  • biosensor devices can be manufactured at a low cost, when compared to current manufacturing methods.
  • Another advance, which is again significant is the ability to test the individual fibers before they are formed into a bundle for quality assurance purposes. Testing can be performed by cleaving a functional moiety off of an individual fiber sample and quality control can be performed on the cleaved functional moiety. This is not possible with present biosensor chips, which utilize photolithography or other techniques to bond a plurality of different functional moieties to different locations upon the chip.
  • Fig. 4 shows a biosensor device 10 manufactured according to the principles of the present invention.
  • the biosensor device 10 is comprised of a plurality of individual fibers 12 upon which functional moieties have been synthesized. As explained earlier, the fibers are arranged and bonded in their arrangement using a bonding medium 14, which substantially fills the interstitial spaces intermediate the individual fibers and thereafter allows the fiber bundle to be sliced into individual chips, (step 140, Fig. 3) . Step 140 may also be accomplished by glass fusion, as is well know in the art, which serves to "bond" the fibers together.
  • the disclosed invention provides a significant improvement over the prior art in providing a cost effective, quality determinative biosensor device and method of their manufacture .

Abstract

A new biosensor device (10) and biosensor device manufacturing method improves upon the prior art by providing high reliability devices that can be manufactured on an extremely cost basis and which are amenable to quality control procedures, which can be performed on individual fibers as well as the devices themselves. The improved biosensor devices are manufactured by first synthesizing a plurality of functional moieties onto a plurality of fibers (100), which may be solid and/or hollow, wherein at least one fiber receives one moiety. Once the functional moieties are synthesized onto the fibers, the fibers are bundled in a predetermined arrangement (120). The bundled fibers are then bonded or fused together to fix their predetermined arrangement (130). Finally, the bonded fiber bundle is sliced into a plurality of individual devices or chips (140).

Description

IMPROVED BIOSENSOR DEVICE AND METHOD OF MANUFACTURING SAME
FIELD OF THE INVENTION This invention relates to a device which can serve as a biosensor device and which is useful for separation and detection of micro quantities of proteins and similar types of genetic materials and organic molecules and to a method of manufacturing such a device, which can be implemented as microarrays which may be used for high throughput screening applications, bioremediation and detection and quantification.
BACKGROUND OF THE INVENTION
There exists a need for reliable, low cost analytical devices that allow for the rapid separation and detection of micro quantities of cellular tissue, genetic material, organic molecules, sequencing, etc. for use in research as well as in the diagnosis of disease (s) or the existence of certain predetermined conditions. DNA analysis is an effective approach for the detection and identification of viruses, bacteria, and other microbes and is essential to the identification of genetic disorders. The ability to detect DNA with a high level of specificity entails high resolution separation of RNA or DNA fragments, appropriate labeling chemistry for such fragments and the adaptation of high sensitivity sensors that are specific for the labeling chemistry employed. DNA probe technology is now an established tool of the molecular biologist for revealing the presence of diagnostically significant cells, whether they be diseased cells from the subject or infectious micro organisms. Recently, DNA analysis devices have experienced a miniaturization trend similar to that experienced in the electronics industry with the advent of integrated circuits. Many of the same principles that have led to smaller and smaller micro processor devices have shrunk the size of a chemistry lab to a device no larger than the size of a dime. The techniques are all aimed at producing a device having different, discreet areas that are sensitive to different genetic sequences. These areas, or probes, are formed using a number of techniques, including photo patterning methods, such as photolithography, which is a direct descendant from techniques used in the manufacture of micro processor chips; micro machining, where tiny channels are machined into a chip to hold various test media; and other methods of precisely depositing test media upon chips in a precisely defined pattern.
While these methods do allow for the manufacture of acceptable biosensor chips, they do have a number of drawbacks. One significant drawback is the sophistication and expense of photo patterning, micro machining and micro-media deposition devices that are capable of producing biosensor chips including hundreds or thousands of individual probes. Additionally, the use of these prior art methods requires extreme precision in the deposition of test materials since their deposition involves microscopic quantities and positions. This also leads to significant quality control issues, since a single biosensor chip can have literally thousands of separate probes, each of which requires testing or verification. Due to these drawbacks and limitations, biosensor chips are expensive to manufacture and although they provide significant improvements in the state of the art, they have not yet experienced wide scale implementation. In addition, the technology is too expensive for implementation with respect to low cost diagnostic tests.
Accordingly, there is a need for an improved biosensor chip or device and method of manufacturing the same, which can result in inexpensive biosensor devices that can be manufactured using cost effective machinery. Additionally, there is a need for a biosensor device that can be highly reliable due to improved quality assurance procedures performed during the manufacture thereof. Finally, a biosensor device is needed that can utilize the same manufacturing methods for a wide variety of analysis protocols including both sophisticated and simple analytical procedures.
SUMMARY OF THE INVENTION
The disclosed invention provides a new biosensor device which improves upon the prior art by providing high reliability sensors that can be manufactured on an extremely low cost basis. The improved biosensor devices are manufactured by first synthesizing a plurality of functional moieties onto a plurality of fibers, wherein each fiber receives one moiety. Once the functional moieties are synthesized onto the fibers, the fibers are bundled in a predetermined arrangement. The bundled fibers are then bonded together to fix their predetermined arrangement. Finally, the bonded fiber bundle is "sliced" into a plurality of devices (chips) . In one preferred embodiment, the fibers comprise glass fibers.
DESCRIPTION OF THE DRAWINGS
These and other features and advantages of the present invention will be better understood by reading the following detailed description, taken together with the drawings wherein: Fig. 1 is a flow diagram showing the steps included in the disclosed method of manufacturing a biosensor device; Fig. 2 is a detailed block diagram of a method of synthesizing DNA onto fibers to be included in the biosensor device of the present invention;
Fig. 3 is a functio nal block diagram of the disclosed method of manufacturing biosensor devices; and
Fig. 4 is a top view of a biosensor device manufactured according to the principles of the present invention. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT Turning now to the Figures, and in particular Figs 1 and 3, an improved method of manufacturing a biosensor device is disclosed. Method 100 begins by synthesizing functional moieties onto a plurality of fibers, step 110. The fibers can be various diameters and may be solid or hollow. At least one fiber receives several moieties of the same species. However, as will become evident below, more than one fiber may receive the same functional moiety. The functional moieties selected will be dependent upon the specific testing protocol or protocols for which the biosensor device is designed. For example, functional moieties may include DNA oligonucleotides for DNA testing biosensor devices. Alternatively, the functional moieties may include proteins, peptides, antibodies or other chemical functional groups. In the preferred embodiment, the fibers comprise glass fibers.
However, the principles of the invention are equally applicable to polymer fibers or other similar elongated fibers.
Once the fibers are synthesized with their respective functional moieties, the fibers are bundled into a predetermined arrangement, step 120, such as a circle, square, etc. The bundled fibers are then bonded to fix the predetermined arrangement, step 130. Bonding may include fiber fusion or any one of a number of well known biologically inert bonding adhesives such as polysulfone adhesive available from Huls of Germany under the brand name glassclad, or other biologically inert adhesive used in the biopharmaceutical industry. The biologically inert bonding medium thus fills the interstices intermediate the plurality of fibers, thereby separating the functional moieties on the plurality of fibers included in the bundle.
Once the bundled fibers are adequately bonded and their predetermined arrangement is fixed, the fiber bundle is sliced, step 140, to form a plurality of individual "chips" or devices. The slices may be along an axis perpendicular to a longitudinal axis of the fibers. Thus, each individual biosensor device may include a portion of each fiber included in the fiber bundle. Of course, different slicing orientations will result in biosensor devices having different configurations. In fact, the invention contemplates linearly aligned fibers, which are bonded in their linear arrangement. The linearly arranged fiber bundle can then be cut to form wafers having linearly orientated fibers upon which the various functional moieties are synthesized.
Since the arrangement of the fibers is determined during the bundling process, a wide variety of devices may be implemented according to the invention. For example, a device may include many fibers that have the same functional moiety synthesized thereupon. These like fibers can be arranged to form a large region responsive to certain chemicals. Thus, larger, macroscopic biosensor devices can be produced.
On the other extreme, the biosensor devices manufactured according to the principles of the present invention could include literally thousands of fibers synthesized with distinct functional moieties. In this case, analysis of such a biosensor device after it is exposed to a sample would require sophisticated readers and processors, such as lasers, micro computers and optical recognition devices. In the preferred embodiment, the glass fibers used are selected from the group consisting of lead borosilicate, soda- lime, rare earth lead, rare earth crown, flint, short flint, crown, silica, fused silica and borosilicate. However, the invention is not limited to these specific types of glass. Fig. 2 shows, in detail, one embodiment of the step of the invention wherein the functional moieties are synthesized onto the fibers. In the example shown, the fibers include glass fibers and the functional moieties synthesized thereupon comprise DNA oligonucleotides. If the invention is practiced using plastic or polymer fibers, the method 200 would begin with step 225.
In the embodiment of the invention utilizing glass fibers, the method 200 begins by treating each glass fiber in generally a 35 percent and 40 percent HC1 solution at substantially 100°C for substantially three hours, step 205. This step exposes the hydroxy group of the glass fibers. In step 210, each HC1 treated glass fiber is washed with deionized water until its pH reaches substantially 6.5. Next, each washed fiber is baked at substantially 120°C for substantially two hours, step 215.
Thereafter, each fiber is cooled to substantially ambient temperature, step 220. At this point, one can directly go to the synthesis column step 225 or a cleavable linkage may be added to the hydroxyl groups, step 228, which allows for the DNA to be cleaved and analyzed after synthesis, for quality control purposes and the like. Then, in step 225, each glass fiber is packed into a synthesis column, such as a one " //mole" column manufactured by PerSeptive Biosystems. The fiber is then ready to accept the syntheses of a DNA oligonucleotide.
A DNA oligonucleotide is synthesized onto the fiber , step 230, using an automated DNA synthesizer such as those available from PerSeptive Biosystems or Perkin Elmer . This is accomplished with either the standard protocol or with a minor variation to the manufacturer' s standard synthesis protocol namely, an increased coupling time . The standard protocol typically has three (3) coupling steps or stages totaling 5 minutes coupling time. The present invention contemplates three (3) coupling stages of 10 minu tes, 4 minutes and 1 minute respectively, although this is not a limitation of the present invention. Coupling time is a factor of the fiber type used and whether or not the fibers are hollow or not.
After the DNA synthesis is completed, the column is dried under a vacuum for substantially ten minutes, step 235. As indicated earlier, if quality control measures are to be implemented to the synthesized fibers, then, in optional step 240, the fiber, which now includes a DNA oligonucleotide synthesized thereupon is treated with a one ml concentrated ammonium hydroxide solution at a temperature of substantially 55°C for a period of substantially six hours. This step will cleave the DNA ologonucleotide (the functional moiety) from the fiber so that it can be analyzed for quality control purposes. Analytical testing, such as absorption measurement of the ammonium hydroxide solution at 260 nm indicates that there is no loss of the DNA oligonucleotide from the glass fiber or if a cleavable linker was added then absorption at 260 nm indicates the presence of DNA.
One of the important improvements over the prior art offered by the disclosed method of making biosensor devices is that they can be manufactured at a low cost, when compared to current manufacturing methods. Another advance, which is again significant is the ability to test the individual fibers before they are formed into a bundle for quality assurance purposes. Testing can be performed by cleaving a functional moiety off of an individual fiber sample and quality control can be performed on the cleaved functional moiety. This is not possible with present biosensor chips, which utilize photolithography or other techniques to bond a plurality of different functional moieties to different locations upon the chip.
Fig. 4 shows a biosensor device 10 manufactured according to the principles of the present invention. The biosensor device 10 is comprised of a plurality of individual fibers 12 upon which functional moieties have been synthesized. As explained earlier, the fibers are arranged and bonded in their arrangement using a bonding medium 14, which substantially fills the interstitial spaces intermediate the individual fibers and thereafter allows the fiber bundle to be sliced into individual chips, (step 140, Fig. 3) . Step 140 may also be accomplished by glass fusion, as is well know in the art, which serves to "bond" the fibers together.
Thus, the disclosed invention provides a significant improvement over the prior art in providing a cost effective, quality determinative biosensor device and method of their manufacture .
Modifications and substitutions by one of ordinary skill in the art are considered to be within the scope of the present invention which is not to be limited except by the claims which follow.

Claims

1. A method of manufacturing biosensor device comprising synthesizing one or more functional moiety onto a plurality of fibers, wherein at least one fiber receives one moiety; bundling said plurality of fibers in a predetermined arrangement; bonding or fixing said bundled plurality of fibers to fix the predetermined arrangement; and slicing said bundled fiber bundle into a plurality of biosensor devices.
2. The method of manufacturing biosensor devices of Claim 1 wherein the step of slicing said bonded fiber bundle comprises cutting the bundle at an angle such that a portion of each fiber included in the bundle is included in each biosensor device.
3. The method of manufacturing biosensor devices of Claim 2, wherein said angle is substantially 90° with respect to a longitudinal axis of the bundled fibers.
4. The method of manufacturing biosensor devices of Claim 1, wherein said at least one functional moiety synthesized onto said fibers comprises DNA oligonucleotides.
5. The method of manufacturing biosensor devices of Claim 1, wherein said at least one functional moiety comprise proteins .
6. The method of manufacturing biosensor devices of Claim 1, wherein said functional moieties comprise peptides.
7. The method of manufacturing biosensor devices of Claim 1, wherein said functional moieties comprise antibodies.
8. The method of manufacturing biosensor devices of Claim 1, wherein said functional moieties comprise chemical functional groups.
9. The method of manufacturing biosensor devices of Claim 4, wherein said step of synthesizing said DNA oligonucleotide onto said fibers comprises: treating each fiber in substantially between a 35 and 40 percent HCl solution at substantially 100°C for substantially three hours; washing each treated fiber with deionized water until the pH of each glass fiber is substantially 6.5; baking each washed fiber at substantially 120 °C for substantially two hours; cooling each fiber to substantially ambient temperature; packing each fiber into a 1 .mole column; synthesizing a DNA oligonucleotide onto said fiber using an automated DNA synthesizer; and drying said fiber under vacuum for substantially ten minutes.
10. The method of manufacturing biosensor devices of Claim 9, further comprising the step of treating said fiber with 1 ml concentrated ammonium hydroxide at substantially 55°C for substantially six hours.
11. The method of manufacturing biosensor devices of Claim 1, wherein said step of bonding said plurality of fibers comprises chemically bonding said fibers using a biologically inert chemical bonding agent, said bonding agent forming biologically inert interstices intermediate the fibers arranging the bundle and thereby separating the functional moieties included on the manufactured biosensor device.
12. The method of manufacturing biosensor devices of Claim 1, wherein said fibers are glass fibers, and further wherein said step of bonding said plurality of fibers comprises glass fusing said glass fibers.
13. A method of manufacturing biosensor devices comprising: applying a plurality of functional moieties onto a plurality of fibers, each of said fibers including a single functional moiety; arranging said plurality of fibers into a bundle, wherein each said fiber is in a predetermined position; fixing said fiber arrangement in said bundle using a chemical bonding technique; and slicing said fiber bundle into individual biosensor devices.
14. An improved biosensor device comprising an individual slice of a plurality of individual fibers, each individual fiber having applied thereto a functional moiety, said individual fibers being arranged in a predetermined fashion, and the arrangement fixed by bonding said fibers together.
15. The improved biosensor device of Claim 14, wherein said fibers comprise glass fibers.
16. The improved biosensor device of Claim 14, wherein said fibers comprise plastic fibers.
17. The improved biosensor device of Claim 15, wherein said fibers comprise quartz fibers.
18. The improved biosensor device of Claim 14, wherein the glass fibers are selected from the group consisting of lead borosilicate, soda lime, borosilicate, rare earth lead, rare earth crown, flint, short flint, crown, silica, and fused silica.
19. The improved biosensor device of Claim 14, wherein said fibers comprise polymer fibers.
20. The improved biosensor device of Claim 14, wherein said fibers comprise hollow fibers.
21. The improved biosensor device of Claim 14, wherein said fibers comprise solid fibers.
PCT/US1999/029965 1998-12-17 1999-12-15 Improved biosensor device and method of manufacturing same WO2000040942A2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
MXPA01006126A MXPA01006126A (en) 1998-12-17 1999-12-15 Improved biosensor device and method of manufacturing same.
AU43241/00A AU4324100A (en) 1998-12-17 1999-12-15 Improved biosensor device and method of manufacturing same
CA002356634A CA2356634A1 (en) 1998-12-17 1999-12-15 Improved biosensor device and method of manufacturing same
EP99972833A EP1166077A4 (en) 1998-12-17 1999-12-15 Improved biosensor device and method of manufacturing same
JP2000592611A JP2002534672A (en) 1998-12-17 1999-12-15 Improved biosensor device and manufacturing method thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/213,587 US6129896A (en) 1998-12-17 1998-12-17 Biosensor chip and manufacturing method
US09/213,587 1998-12-17

Publications (2)

Publication Number Publication Date
WO2000040942A2 true WO2000040942A2 (en) 2000-07-13
WO2000040942A3 WO2000040942A3 (en) 2000-09-21

Family

ID=22795684

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/029965 WO2000040942A2 (en) 1998-12-17 1999-12-15 Improved biosensor device and method of manufacturing same

Country Status (7)

Country Link
US (1) US6129896A (en)
EP (1) EP1166077A4 (en)
JP (1) JP2002534672A (en)
AU (1) AU4324100A (en)
CA (1) CA2356634A1 (en)
MX (1) MXPA01006126A (en)
WO (1) WO2000040942A2 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001009607A1 (en) * 1999-07-30 2001-02-08 Large Scale Proteomics, Corp. Microarrays and their manufacture
WO2002005945A1 (en) * 2000-07-14 2002-01-24 Max-Delbrück-Centrum für Molekulare Medizin Method for producing microarray chips with nucleic acids, proteins or other test substrates
WO2002075027A1 (en) * 2001-03-15 2002-09-26 Large Scale Proteomics Corporation Method and apparatus for making fibers for sectioned arrays
WO2002076608A2 (en) * 2001-02-28 2002-10-03 Attomol Gmbh Molekulare Diagnostika Method for producing an array for detecting constituents from a biological sample

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7019827B2 (en) * 1997-06-16 2006-03-28 Diversa Corporation GigaMatrix holding tray having through-hole wells
EP1090293B2 (en) 1998-06-24 2019-01-23 Illumina, Inc. Decoding of array sensors with microspheres
AU2830400A (en) 1999-03-05 2000-09-28 Mitsubishi Rayon Company Limited Carriers having biological substance
US20030129654A1 (en) * 1999-04-15 2003-07-10 Ilya Ravkin Coded particles for multiplexed analysis of biological samples
US20030207249A1 (en) * 1999-04-15 2003-11-06 Beske Oren E. Connection of cells to substrates using association pairs
US6908737B2 (en) * 1999-04-15 2005-06-21 Vitra Bioscience, Inc. Systems and methods of conducting multiplexed experiments
US7253435B2 (en) * 1999-04-15 2007-08-07 Millipore Corporation Particles with light-polarizing codes
US20040018485A1 (en) * 1999-04-15 2004-01-29 Ilya Ravkin Multiplexed analysis of cells
US20030134330A1 (en) * 1999-04-15 2003-07-17 Ilya Ravkin Chemical-library composition and method
JP3957118B2 (en) * 1999-05-18 2007-08-15 富士フイルム株式会社 Test piece and image information reading device from the test piece
US20020015952A1 (en) * 1999-07-30 2002-02-07 Anderson Norman G. Microarrays and their manufacture by slicing
US20020039728A1 (en) * 2000-02-10 2002-04-04 Robert Kain Alternative substrates and formats for bead-based array of arrays
US6770441B2 (en) 2000-02-10 2004-08-03 Illumina, Inc. Array compositions and methods of making same
EP1299713A1 (en) * 2000-02-28 2003-04-09 Variom Biotechnology AG Component comprising a plurality of fiber elements and sample molecules that are immobilized on said fiber elements
KR100359941B1 (en) * 2000-04-14 2002-11-07 엘지전자 주식회사 method for fabricating the biochip
JP3510882B2 (en) * 2000-06-20 2004-03-29 三菱レイヨン株式会社 Biologically related substance microarray and manufacturing method thereof
GB0024276D0 (en) * 2000-10-04 2000-11-15 Univ Cranfield Substrate specific materials
JP2004537712A (en) * 2000-10-18 2004-12-16 バーチャル・アレイズ・インコーポレーテッド Multiple cell analysis system
DE10117135A1 (en) * 2001-04-05 2002-10-17 Biotechnolog Forschung Gmbh Method for making a plurality of identical copies of a planar test assembly of probe molecules
US20030022394A1 (en) * 2001-07-27 2003-01-30 Dumas David P. Biochips and methods of making same
US20030219800A1 (en) * 2001-10-18 2003-11-27 Beske Oren E. Multiplexed cell transfection using coded carriers
AU2003213791A1 (en) * 2002-03-05 2003-09-22 Vitra Bioscience, Inc. Multiplexed cell transfection using coded carriers
WO2003076900A2 (en) * 2002-03-05 2003-09-18 Vitra Bioscience, Inc. Multiplexed analysis of cell-substrate interactions
US8048623B1 (en) 2002-04-24 2011-11-01 The University Of North Carolina At Greensboro Compositions, products, methods and systems to monitor water and other ecosystems
US8383342B2 (en) 2002-04-24 2013-02-26 The University Of North Carolina At Greensboro Compositions, products, methods and systems to monitor water and other ecosystems
US9126165B1 (en) 2002-04-24 2015-09-08 The University Of North Carolina At Greensboro Nucleic acid arrays to monitor water and other ecosystems
US20040126773A1 (en) * 2002-05-23 2004-07-01 Beske Oren E. Assays with coded sensor particles to sense assay conditions
CA2513985C (en) 2003-01-21 2012-05-29 Illumina Inc. Chemical reaction monitor
WO2004101414A1 (en) * 2003-05-19 2004-11-25 Mitsubishi Rayon Co., Ltd. Yarn arrangement device and method for yarn arrangement using the device, yarn arrangement tool, method of manufacturing yarn arranged body, and method of manufacturing living body-related substance immobilizing micro array
US7488451B2 (en) * 2003-09-15 2009-02-10 Millipore Corporation Systems for particle manipulation
US20050084914A1 (en) * 2003-09-15 2005-04-21 Foulkes J. G. Assays with primary cells
EP2407242A1 (en) * 2010-07-13 2012-01-18 Dublin City University Direct clone analysis and selection technology
JP5660468B2 (en) * 2011-03-15 2015-01-28 三菱レイヨン株式会社 Method for producing gel microarray for detecting bio-related substances
KR101652177B1 (en) * 2013-10-28 2016-08-31 서울대학교산학협력단 Sliced Fiber Composite for Multiplex Bioassay
WO2020173507A1 (en) * 2019-02-27 2020-09-03 北京市理化分析测试中心 Carbon fibre bundle sample and preparation method therefor

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5320814A (en) * 1991-01-25 1994-06-14 Trustees Of Tufts College Fiber optic array sensors, apparatus, and methods for concurrently visualizing and chemically detecting multiple analytes of interest in a fluid sample
US5545531A (en) * 1995-06-07 1996-08-13 Affymax Technologies N.V. Methods for making a device for concurrently processing multiple biological chip assays
US5690894A (en) * 1995-05-23 1997-11-25 The Regents Of The University Of California High density array fabrication and readout method for a fiber optic biosensor
WO1999055460A1 (en) * 1998-04-27 1999-11-04 Corning Incorporated Redrawn capillary imaging reservoir

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4103064A (en) * 1976-01-09 1978-07-25 Dios, Inc. Microdevice substrate and method for making micropattern devices
US4302530A (en) * 1977-12-08 1981-11-24 University Of Pennsylvania Method for making substance-sensitive electrical structures by processing substance-sensitive photoresist material
GB8314523D0 (en) * 1983-05-25 1983-06-29 Lowe C R Diagnostic device
US4908112A (en) * 1988-06-16 1990-03-13 E. I. Du Pont De Nemours & Co. Silicon semiconductor wafer for analyzing micronic biological samples
US5200051A (en) * 1988-11-14 1993-04-06 I-Stat Corporation Wholly microfabricated biosensors and process for the manufacture and use thereof
US5244636A (en) * 1991-01-25 1993-09-14 Trustees Of Tufts College Imaging fiber optic array sensors, apparatus, and methods for concurrently detecting multiple analytes of interest in a fluid sample
US5585069A (en) * 1994-11-10 1996-12-17 David Sarnoff Research Center, Inc. Partitioned microelectronic and fluidic device array for clinical diagnostics and chemical synthesis
US5736257A (en) * 1995-04-25 1998-04-07 Us Navy Photoactivatable polymers for producing patterned biomolecular assemblies
US5661028A (en) * 1995-09-29 1997-08-26 Lockheed Martin Energy Systems, Inc. Large scale DNA microsequencing device
US5837196A (en) * 1996-01-26 1998-11-17 The Regents Of The University Of California High density array fabrication and readout method for a fiber optic biosensor
US5760130A (en) * 1997-05-13 1998-06-02 Molecular Dynamics, Inc. Aminosilane/carbodiimide coupling of DNA to glass substrate
US6037186A (en) * 1997-07-16 2000-03-14 Stimpson; Don Parallel production of high density arrays

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5320814A (en) * 1991-01-25 1994-06-14 Trustees Of Tufts College Fiber optic array sensors, apparatus, and methods for concurrently visualizing and chemically detecting multiple analytes of interest in a fluid sample
US5690894A (en) * 1995-05-23 1997-11-25 The Regents Of The University Of California High density array fabrication and readout method for a fiber optic biosensor
US5545531A (en) * 1995-06-07 1996-08-13 Affymax Technologies N.V. Methods for making a device for concurrently processing multiple biological chip assays
WO1999055460A1 (en) * 1998-04-27 1999-11-04 Corning Incorporated Redrawn capillary imaging reservoir

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1166077A2 *

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001009607A1 (en) * 1999-07-30 2001-02-08 Large Scale Proteomics, Corp. Microarrays and their manufacture
EP1204867A1 (en) * 1999-07-30 2002-05-15 Large Scale Proteomics Corporation Microarrays and their manufacture
EP1204867A4 (en) * 1999-07-30 2006-05-10 Large Scale Proteomics Corp Microarrays and their manufacture
WO2002005945A1 (en) * 2000-07-14 2002-01-24 Max-Delbrück-Centrum für Molekulare Medizin Method for producing microarray chips with nucleic acids, proteins or other test substrates
WO2002076608A2 (en) * 2001-02-28 2002-10-03 Attomol Gmbh Molekulare Diagnostika Method for producing an array for detecting constituents from a biological sample
WO2002076608A3 (en) * 2001-02-28 2003-12-11 Attomol Gmbh Molekulare Diagno Method for producing an array for detecting constituents from a biological sample
US7005294B2 (en) 2001-02-28 2006-02-28 Attomol Moleulare Diagnostika Gmbh Method for producing an array for detecting constituents from a biological sample
WO2002075027A1 (en) * 2001-03-15 2002-09-26 Large Scale Proteomics Corporation Method and apparatus for making fibers for sectioned arrays

Also Published As

Publication number Publication date
EP1166077A4 (en) 2002-03-20
EP1166077A2 (en) 2002-01-02
US6129896A (en) 2000-10-10
CA2356634A1 (en) 2000-07-13
WO2000040942A3 (en) 2000-09-21
MXPA01006126A (en) 2002-09-18
JP2002534672A (en) 2002-10-15
AU4324100A (en) 2000-07-24

Similar Documents

Publication Publication Date Title
US6129896A (en) Biosensor chip and manufacturing method
US6875620B1 (en) Tiling process for constructing a chemical array
US6309831B1 (en) Method of manufacturing biological chips
AU2002232193B2 (en) Microchip
EP0969083B1 (en) Dna capillary
US7964388B2 (en) Chemical reaction device, chemical reaction system, and chemical reaction method
EP1250954B1 (en) Microchannel device, method for producing the microchannel device and use of the same
JPH05236997A (en) Chip for catching polynucleotide
US20080254997A1 (en) Kit, Device and Method For Analyzing Biological Substance
JP2000515632A (en) Discs, devices for performing assays, assay elements, and assay components
KR20000071894A (en) Multipurpose diagnostic systems using protein chips
US7642097B2 (en) Manufacture and use of non-standard size microarray slides
KR100848636B1 (en) Selectively hybridizable substance immobilization fiber, fiber array comprising bundle of such fibers, selective hybridizing method, device therefor, and base
EP1229129A2 (en) Affinity detecting/analytical chip, method for production thereof, detection method and detection system using same
JP2008134188A (en) Probe solidifying reaction array and manufacturing method of array
US20070020668A1 (en) Method of manufacturing
EP1271149A2 (en) Structure with immobilized biological material and method for manufacturing the same
US20040197787A1 (en) Affinity reaction probe detection/analysis chips and detection system and apparatus using the same
US6491869B1 (en) Method for preparing assay supports having an ordered set of reaction zones
US20020168655A1 (en) Method of manufacturing
JP2002139494A (en) Method for fixing microorganism, nucleic acid, and protein and its series and method for analysis

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
ENP Entry into the national phase

Ref document number: 2356634

Country of ref document: CA

Ref country code: CA

Ref document number: 2356634

Kind code of ref document: A

Format of ref document f/p: F

Ref country code: JP

Ref document number: 2000 592611

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: PA/a/2001/006126

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 1999972833

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 1999972833

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1999972833

Country of ref document: EP